Rodrigue Brossaud | Gastrointestinal Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Rodrigue Brossaud | Gastrointestinal Pharmacology | Best Researcher Award

McMaster University | Canada

Dr. Rodrigue Brossaud is a distinguished neuroscientist and postdoctoral fellow specializing in neurogastroenterology at McMaster University in Canada, working under the guidance of Dr. Elyanne Ratcliffe at the Farncombe Institute. Supported by a prestigious DeGroote Postdoctoral Award, his research explores how prenatal cannabis exposure influences the development of the microbiota–gut–brain axis, emphasizing the pivotal role of the endocannabinoid system in the maturation of both the enteric and central nervous systems. His work bridges developmental neurobiology, microbiome science, and neuropharmacology, offering groundbreaking insight into how early-life environmental exposures can shape lifelong neurological and gastrointestinal health.Dr. Brossaud earned his Ph.D. in Neuroscience from Nantes University, where his doctoral research in the TENS Laboratory at the Faculty of Medicine, under the mentorship of Prof. Michel Neunlist and Dr. Moustapha Cissé, focused on the beneficial effects of bacterial metabolites on early intestinal amyloid pathology in a mouse model of Alzheimer’s disease. His findings highlighted the therapeutic potential of gut-derived microbial compounds in modulating neuroinflammation and amyloid accumulation, laying the groundwork for novel microbiota-based strategies in neurodegenerative disease management.Before his doctorate, he completed a Master’s in Biology, Biotechnology, and Therapeutic Research at Nantes University with honors, conducting an advanced study on the role of interactions between CD4 T cells and enteric glial cells in early relapses of Crohn’s disease, supervised by Prof. Philippe Naveilhan. His bachelor’s degree in Animal Physiology and Cellular Biology, also earned with honors, and his intensive preparatory studies in Biology, Chemistry, Physics, and Earth Sciences at Georges Clemenceau High School, further strengthened his multidisciplinary scientific foundation.

Profile: Orcid

Featured Publications

Brossaud, R., Moullé, V. S., Giblaine, M., Even, S., Maillard, M.-B., Chevalier, S., Oullier, T., Guédon, E., Le Loir, Y., Cissé, M., et al. (2025, December). Microbial metabolites alleviate Aß-induced alterations of intestinal epithelial barrier and enteric nervous system connectivity. Journal of Functional Foods, 107095.

Le Berre, C., Durand, T., Pabois, J., Brossaud, R., Aymeric, L., Neunlist, M., Bourreille, A., Naveilhan, P., & Neveu, I. (2025, June 1). Enteric glia promotes the survival of CD4 and CD8 T cells in plexitis: A new player in Crohn’s disease recurrence? American Journal of Physiology – Gastrointestinal and Liver Physiology.

Parvin Babaei | Neuropharmacology | Women Researcher Award

Published on by Top Pharmaceutical

Prof. Parvin Babaei | Neuropharmacology | Women Researcher Award

Guilan University of Medical Sciences | Iran

Prof. Parvin Babaei is a distinguished physiologist and neuroscientist whose research bridges the complex domains of neuromolecular biology, neurophysiology, and behavioral sciences. She earned her Ph.D. in Physiology with a specialization in Neuromolecular Biology from the Russian Academy of Medical Sciences, Anokhin Institute of Normal Physiology in Moscow, following her M.Sc. in Human Physiology from the University of Tarbiat Modarres in Tehran and a B.Sc. in Biology from the University of Guilan, Iran. Her academic foundation and scientific curiosity have driven her to explore the molecular and behavioral mechanisms underlying neurological and physiological functions in both animal and human models.Prof. Babaei’s scientific contributions encompass a broad spectrum of research areas including gene expression, neurobehavioral assessment, and experimental modeling of neurological disorders such as Alzheimer’s, Parkinson’s, stroke, and metabolic syndrome. She possesses advanced technical expertise in immunohistochemistry, enzyme-linked immunosorbent assay (ELISA), stereotaxic surgery, behavioral and motor tracking with Ethovision software, and diverse learning and memory assessment tools such as the Morris Water Maze, passive avoidance, and object recognition tasks. Her experimental approach integrates molecular techniques with behavioral analysis to uncover the biological basis of stress, cognition, and neurodegeneration.She has made remarkable scholarly contributions with numerous impactful publications, such as Stress induced expression of c-fos in the rat brain: a comparison of averaging and individual analyses, Apamine increases excitability of CA1 hippocampal pyramidal neurons, and Characteristics of c-fos gene expression in the brains of rats with different investigative and defensive behaviors. Her works like Mapping pattern of c-fos expression after seizure using immunoperoxidase staining, Effect of aerobic training on serum IgG and IgA of male students, Effect of Atrial Natriuretic Peptide on spontaneous activity of rat uterine smooth muscle, and Effect of training on visceral fat in ovariectomized rats reflect her interdisciplinary command across physiology, neuroscience, and exercise science.Throughout her career, Prof. Babaei has been recognized with numerous honors, including several “Best Researcher” awards from Guilan University of Medical Sciences and the Guilan Province, and distinction among the world’s top 2% scientists identified by Stanford University.

Profile: Google Scholar

Featured Publications

Damirchi, A., Hosseini, F., & Babaei, P. (2018). Mental training enhances cognitive function and BDNF more than either physical or combined training in elderly women with MCI: A small-scale study. American Journal of Alzheimer’s Disease & Other Dementias®, 33(1), 20–29.

Kouhestani, S., Jafari, A., & Babaei, P. (2018). Kaempferol attenuates cognitive deficit via regulating oxidative stress and neuroinflammation in an ovariectomized rat model of sporadic dementia. Neural Regeneration Research, 13(10), 1827–1832.

Babaei, P. (2021). NMDA and AMPA receptors dysregulation in Alzheimer’s disease. European Journal of Pharmacology, 908, 174310.

Fayaz, E., Damirchi, A., Zebardast, N., & Babaei, P. (2019). Cinnamon extract combined with high-intensity endurance training alleviates metabolic syndrome via non-canonical WNT signaling. Nutrition, 65, 173–178.

Babaei, P., Mehdizadeh, R., Ansar, M. M., & Damirchi, A. (2010). Effects of ovariectomy and estrogen replacement therapy on visceral adipose tissue and serum adiponectin levels in rats. Menopause International, 16(3), 100–104.

Supraja R Prasad | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Ms. Supraja R Prasad | Drug Discovery and Development | Best Researcher Award

Kuvempu University | India

Ms. Supraja R. Prasad is a passionate researcher and educator specializing in organic synthesis, computational chemistry, and the design of biologically active heterocycles. Her academic and professional journey reflects a deep dedication to the integration of sustainable chemical methodologies with modern computational tools to advance the field of drug discovery. She is particularly recognized for her innovative work on the green synthesis of heterocyclic compounds, utilizing eco-friendly multicomponent reactions and natural catalysts to create molecular frameworks with promising therapeutic potential.Her research portfolio spans multiple interrelated areas, including mechanochemical synthesis of heterocyclic derivatives, density functional theory (DFT) studies, and spectral characterization of synthesized compounds. She has also explored the anti-diabetic activity of synthesized derivatives, focusing on developing safer and more efficient alpha-glucosidase inhibitors for managing type 2 diabetes mellitus. By combining experimental synthesis with computational modeling and molecular docking analyses, Ms. Prasad bridges the gap between theoretical chemistry and practical pharmacological applications.Her recent publication in the Journal of the Indian Chemical Society highlights her contributions to the synthesis and evaluation of alpha-glucosidase inhibitors, further strengthening her position within the scientific community. Through her work, she demonstrates how green chemistry can drive meaningful advancements in pharmaceutical sciences while minimizing environmental impact.Ms. Prasad’s academic mission is rooted in the belief that collaborative, interdisciplinary research can accelerate innovation. She emphasizes teamwork, creativity, and knowledge sharing as the cornerstones of impactful scientific progress. Her approach integrates sustainability, molecular insight, and therapeutic relevance — a combination that continues to shape her vision for future research.Her ongoing studies and contributions to organic synthesis, bioactivity assessment, and computational modeling position her as an emerging leader in sustainable chemistry and computational drug discovery, striving to make scientific research both environmentally responsible and socially beneficial.

Profile: Orcid

Featured Publications

Clay catalyzed dihydropyrimidinone synthesis: α-glucosidase inhibition and chemoinformatics. Journal of the Indian Chemical Society.

Lorena Garcia Hevia | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Lorena Garcia Hevia | Drug Delivery Systems | Best Researcher Award

Universidade de Vigo | Spain

Dr. Lorena García Hevia is a distinguished researcher recognized for her pioneering work at the intersection of nanomedicine, microbiology, and biotechnology. As a member of the Hybrid Nanomaterials Research Group at the Galicia Sur Health Research Institute (IIS Galicia Sur), she has dedicated her career to advancing innovative nanotechnological solutions that address critical biomedical challenges. Her research focuses primarily on the design and application of nanoscale systems to improve therapeutic delivery, particularly within the context of infectious disease management and antimicrobial resistance.Affiliated with the CINBIO (Biomedical Research Center) and the Universidade de Vigo in Spain, Dr. García Hevia brings an interdisciplinary approach that bridges biochemical, genetic, and immunological insights with advanced materials science. Her scientific vision emphasizes the development of intelligent nanocarriers that enhance drug stability, optimize bioavailability, and enable targeted therapy. Through this approach, she contributes to transforming conventional treatments into highly efficient, patient-specific solutions.In her recent publication Nanomedicine for Phage Therapy: Encapsulation Strategies for Enhanced Antimicrobial Efficacy, Dr. García Hevia and her colleagues explore the integration of nanotechnology with bacteriophage therapy to overcome limitations in traditional antimicrobial strategies. Her work demonstrates how encapsulation methods—such as polymeric nanoparticles, liposomes, hydrogels, and nanofibers—can significantly improve the stability, delivery, and therapeutic impact of bacteriophages. These innovative formulations facilitate localized and sustained release, providing powerful alternatives against multidrug-resistant infections.Dr. García Hevia’s research is marked by creativity, precision, and translational relevance. Her investigations into responsive nanocarriers and inorganic nanoparticles have opened new avenues for targeted phage delivery, aligning with global efforts to combat antibiotic resistance through sustainable and effective biotechnological interventions. Beyond her scientific achievements, she is deeply engaged in academic mentorship and collaborative research initiatives that strengthen the connection between laboratory innovation and clinical application.Her contributions continue to shape the evolving field of nanomedicine, positioning her as a leading figure in the development of next-generation antimicrobial therapies. Through her commitment to excellence and scientific innovation, Dr. Lorena García Hevia exemplifies the transformative potential of nanotechnology in redefining the future of infection control and precision therapeutics.

Profile: Google Scholar

Featured Publications

García‐Hevia, L., Bañobre‐López, M., & Gallo, J. (2019). Recent progress on manganese‐based nanostructures as responsive MRI contrast agents. Chemistry–A European Journal, 25(2), 431–441.

García-Hevia, L., Valiente, R., Martín-Rodríguez, R., Renero-Lecuna, C., et al. (2016). Nano-ZnO leads to tubulin macrotube assembly and actin bundling, triggering cytoskeletal catastrophe and cell necrosis. Nanoscale, 8(21), 10963–10973.

Rodrigues, R. O., Baldi, G., Doumett, S., García-Hevia, L., Gallo, J., et al. (2018). Multifunctional graphene-based magnetic nanocarriers for combined hyperthermia and dual stimuli-responsive drug delivery. Materials Science and Engineering: C, 93, 206–217.

García‐Hevia, L., Villegas, J. C., Fernández, F., Casafont, Í., González, J., et al. (2016). Multiwalled carbon nanotubes inhibit tumor progression in a mouse model. Advanced Healthcare Materials, 5(9), 1080–1087.

García-Hevia, L., Casafont, I., Oliveira, J., Terán, N., Fanarraga, M. L., & Gallo, J. (2022). Magnetic lipid nanovehicles synergize the controlled thermal release of chemotherapeutics with magnetic ablation while enabling non-invasive monitoring by MRI for melanoma. Bioactive Materials, 8, 153–164.

Zaneta Nikolovska-Coleska | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Dr. Zaneta Nikolovska-Coleska | Drug Discovery and Development | Best Researcher Award

University of Michigan Medical School Department of Pathology | United States

Prof. Dr. Zaneta Nikolovska-Coleska is an accomplished pharmaceutical chemist and molecular pharmacologist recognized for her groundbreaking work in the design, synthesis, and development of molecularly targeted small molecules for cancer treatment. She earned her foundational and advanced degrees in pharmaceutical chemistry from the Faculty of Pharmacy at the University Ss. Cyril and Methodius in Skopje, where she also began her academic career as a young assistant and later advanced through multiple teaching and research positions. Her dedication to chemical sciences and biomedical innovation led her to the University of Michigan, Ann Arbor, where she currently serves as a Professor in the Department of Pathology and Associate Dean for Graduate and Postdoctoral Studies.Dr. Nikolovska-Coleska’s research is centered on the discovery of small molecule inhibitors that target protein–protein interactions involved in apoptosis, oncogenic signaling pathways, and epigenetic regulation. Her laboratory investigates mechanisms such as Mcl-1–Bim/Noxa, Bfl-1–Bim/Noxa, EZH2–p38 MAP kinase interactions, and histone methyltransferase activities, contributing to the identification of novel therapeutic targets for various malignancies. Through her integrative approach, combining chemical biology, medicinal chemistry, and translational oncology, she has developed promising compounds for the modulation of signaling pathways implicated in cancer progression and resistance.Her clinical and translational research extends into precision medicine, where she applies functional assays to predict anti-cancer drug responses, aiming to enhance individualized therapeutic strategies. As a clinician-research scholar and educator, she has mentored numerous postdoctoral fellows, clinical trainees, and graduate students, guiding them in developing innovative research methodologies and critical scientific reasoning.Throughout her illustrious career, Dr. Nikolovska-Coleska has played pivotal roles in multiple large-scale research initiatives, serving as Principal Investigator, Co-Investigator, and Mentor on numerous national and international grants focused on cancer biology, aging, and drug discovery. Her collaborations with global scientific institutions and pharmaceutical organizations have contributed to the advancement of targeted therapies, including the development of inhibitors against oncogenic proteins such as DOT1L, Mcl-1, EZH2, and PAPP-A.In addition to her research excellence, Dr. Nikolovska-Coleska has made outstanding contributions to academic leadership. As Director of the Molecular and Cellular Pathology Graduate Program and Associate Director of Academic Programs in Biomedical Sciences, she has overseen curriculum development, student recruitment, academic policy, and interdisciplinary research training. Her vision continues to shape the next generation of biomedical scientists, emphasizing the integration of molecular insights with clinical applications.Through her scholarly achievements, mentorship, and leadership, Prof. Dr. Zaneta Nikolovska-Coleska stands as a leading figure in pharmaceutical chemistry and translational oncology, dedicated to advancing science that bridges molecular discovery with therapeutic innovation.

Profile: Google Scholar

Featured Publications

Ding, K., Lu, Y., Nikolovska-Coleska, Z., Wang, G., Qiu, S., Shangary, S., Gao, W., et al. (2006). Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2−p53 interaction. Journal of Medicinal Chemistry, 49(12), 3432–3435.

Shangary, S., Qin, D., McEachern, D., Liu, M., Miller, R. S., Qiu, S., et al. (2008). Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition. Proceedings of the National Academy of Sciences, 105(10), 3933–3938.

Ding, K., Lu, Y., Nikolovska-Coleska, Z., Qiu, S., Ding, Y., Gao, W., Stuckey, J., et al. (2005). Structure-based design of potent non-peptide MDM2 inhibitors. Journal of the American Chemical Society, 127(29), 10130–10131.

Nikolovska-Coleska, Z., Wang, R., Fang, X., Pan, H., Tomita, Y., Li, P., Roller, P. P., et al. (2004). Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization. Analytical Biochemistry, 332(2), 261–273.

Nikolovska-Coleska, Z., Xu, L., Hu, Z., Tomita, Y., Li, P., Roller, P. P., Wang, R., et al. (2004). Discovery of embelin as a cell-permeable, small-molecular-weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine. Journal of Medicinal Chemistry, 47(10), 2430–2440.

Bagherian, M., Sabeti, E., Wang, K., Sartor, M. A., Nikolovska-Coleska, Z., et al. (2021). Machine learning approaches and databases for prediction of drug–target interaction: A survey paper. Briefings in Bioinformatics, 22(1), 247–269.

Wang, G., Nikolovska-Coleska, Z., Yang, C. Y., Wang, R., Tang, G., Guo, J., et al. (2006). Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins. Journal of Medicinal Chemistry, 49(21), 6139–6142.

Ali Raza Ayub | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Mr. Ali Raza Ayub | Drug Delivery Systems | Best Researcher Award

Beijing Institute of Technology | Pakistan

Mr. Ali Raza Ayub is a passionate and accomplished researcher in organic and computational chemistry, with extensive experience in nanomaterials, catalysis, and environmental chemistry. He completed his M.Phil. in Organic Chemistry and M.Sc. in Chemistry from the University of Agriculture, Faisalabad, where he consistently demonstrated academic excellence and research aptitude. His academic focus has been on molecular modeling, nanochemistry, and material synthesis, combining theoretical and experimental approaches to solve real-world challenges.Currently affiliated with the Computational Lab, Department of Chemistry, University of Agriculture, Faisalabad, Mr. Ayub’s research centers on quantum-level molecular studies and photocatalytic material development. His expertise covers a broad spectrum of analytical and instrumental techniques, including UV-Vis spectroscopy, FTIR, XRD, SEM, and various chromatographic methods. His significant study, “Synthesis and Characterization of a Tertiary Composite of Cu, Mn, and g-C3N4: An Efficient Visible Light-Active Catalyst for Wastewater Treatment,” illustrates his innovative work on developing eco-friendly photocatalysts for environmental remediation.Mr. Ayub has co-authored multiple impactful publications in reputed journals, such as “Biomimetic Synthesis and Characterization of Silver Nanoparticles from Dipterygium glaucum Extract and Its Anti-Cancerous Activities,” “Synthesis of Nickel, Calcium and Magnesium Naphthalene Diimide Complexes as Supercapacitor Materials,” and “Synthesis, Combined Theoretical and Spectral Characterization of Some New 1,3,5-Triazine Compounds and Their In Vitro Biological Analysis.” His multidisciplinary work spans green chemistry, renewable energy, and bioactive compound synthesis, integrating computational modeling with experimental chemistry.He has participated in several international symposia, workshops, and conferences, contributing to collaborative scientific discussions. With 661 citations by 538 documents, 61 publications, and an h-index of 13, Mr. Ayub has established a solid academic reputation. Recipient of the Benevolent Fund Punjab Scholarship Award, he continues to advance research in sustainable chemistry, demonstrating excellence in both scientific innovation and educational contribution.

Profile: Scopus

Featured Publications

Author(s). (2025). An in-silico study of supramolecular interactions between 2,6-diisopropylphenyl derivatives of PDI and their GMP-doped composites to tune their optoelectronic response. Inorganic Chemistry Communications.

Author(s). (2025). Investigating the optoelectronic properties of Perylene Diimide-based organic molecules for high-efficiency organic solar cells. Computational and Theoretical Chemistry.

Author(s). (2025). Terpyridine–metal architectures (Zn, Cu, Fe) for energy storage: Electrochemical analysis and theoretical modeling. Journal of Electroanalytical Chemistry.

Author(s). (2025). Design of the opto-electronic characteristics of organo-solar cells using the small molecules based on Ullazine. Journal of Molecular Graphics and Modelling.

Author(s). (2025). Quantum simulation and experimental characterization of gold nanorods for DNA sensing applications. Chemical Engineering Science.

Author(s). (2025). Green synthesis of high surface area of reduced graphene oxide via Aloe vera extract: Characterization, DFT mechanistic insights, and enhanced Rhodamine B adsorption using Chitosan@EDTA@rGO composite.

Yuqing Huo | Cardiovascular Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Yuqing Huo | Cardiovascular Pharmacology | Best Researcher Award

Baylor College of Medicine | United States

Prof. Yuqing Huo, Ph.D., is a distinguished cardiovascular and vascular biology researcher whose work bridges molecular mechanisms and clinical applications in inflammation, angiogenesis, and metabolic disease. A U.S. citizen with an extensive background in biomedical science, he currently serves as Professor and Danny B. Jones Chair at the Department of Ophthalmology, Department of Medicine/Section of Cardiovascular Research, and Department of Molecular and Cellular Biology at Baylor College of Medicine in Houston, Texas. His academic journey has been defined by a lifelong dedication to understanding vascular inflammation, endothelial function, and cellular metabolism in cardiovascular and ocular diseases.Prof. Huo earned his Medical Degree from Jining Medical College, followed by a Master’s in Cardiology from Qingdao University and a Doctoral Degree in Molecular Cardiology from Beijing Medical University. He further advanced his expertise as a Postdoctoral Research Associate in Inflammation and Vascular Biology at the University of Virginia, where he worked in Dr. Klaus Ley’s renowned laboratory at the Cardiovascular Research Center. His postdoctoral research laid the foundation for his later breakthroughs in vascular inflammation, monocyte recruitment, and endothelial interactions in atherosclerosis.Over his distinguished academic career, Prof. Huo has held faculty positions at several leading institutions, including the University of Virginia, the University of Minnesota, and Augusta University, where he served as Professor, Chief of the Vascular Inflammation Program, and Director of the Vision Discovery Institute. His leadership in the field has shaped numerous interdisciplinary programs that integrate cardiovascular and ocular research, expanding the understanding of inflammation and angiogenesis in chronic diseases.His scientific achievements have been widely recognized through numerous honors and awards, including distinctions from the American Heart Association, the American Physiological Society, and the American Diabetes Association. His accolades include the New Investigator Award, Young Investigator Award, and several institutional honors for outstanding research contributions and academic excellence.Prof. Huo’s active research focuses on “Myeloid glycolysis in pathological ocular angiogenesis,” “Myeloid PFKFB3 in subretinal fibrosis,” “Adenosine receptor 2A in subretinal fibrosis,” and “VSMC PFKFB3 in atherogenesis,” among others. His projects, supported by the National Institutes of Health (NIH) and the American Heart Association (AHA), aim to uncover novel molecular targets that regulate inflammation, fibrosis, and vascular remodeling. Through the use of genetically engineered models and molecular approaches, his research explores glycolytic reprogramming in immune cells and vascular tissues, paving the way for innovative therapeutic strategies in cardiovascular, metabolic, and ocular disorders.

Profile: Google Scholar

Featured Publications

Cheng, Y., Liu, X., Yang, J., Lin, Y., Xu, D. Z., Lu, Q., Deitch, E. A., Huo, Y., Delphin, E. S., & Zhang, C. (2009). MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circulation Research, 105(2), 158–166.

Huo, Y., Hafezi-Moghadam, A., & Ley, K. (2000). Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions. Circulation Research, 87(2), 153–159.

Huo, Y., Schober, A., Forlow, S. B., Smith, D. F., Hyman, M. C., Jung, S., Littman, D. R., Weber, C., & Ley, K. F. (2003). Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nature Medicine, 9(1), 61–67.

Luo, X., Li, H., Ma, L., Zhou, J., Guo, X., Woo, S. L., Pei, Y., Knight, L. R., Deveau, M., Yang, S., & Huo, Y. (2018). Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice. Gastroenterology, 155(6), 1971–1984.e4.

Node, K., Huo, Y., Ruan, X., Yang, B., Spiecker, M., Ley, K., Zeldin, D. C., & Liao, J. K. (1999). Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science, 285(5431), 1276–1279.

Ramos, C. L., Huo, Y., Jung, U., Ghosh, S., Manka, D. R., Sarembock, I. J., & Ley, K. (1999). Direct demonstration of P-selectin– and VCAM-1–dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E–deficient mice. Circulation Research, 84(11), 1237–1244.

Ameni Gouider | Formulation Science | Best Researcher Award

Published on by Top Pharmaceutical

Ms. Ameni Gouider | Formulation Science | Best Researcher Award

Faculty of Sciences of Gabes | Tunisia

Ms. Ameni Gouider is an emerging researcher in electrochemical water treatment and environmental chemistry, dedicated to developing sustainable solutions for the remediation of industrial effluents, particularly from the pharmaceutical sector. She is currently pursuing a Doctorate in Water Treatment by Electrochemistry at the Faculty of Sciences of Gabès, Tunisia, where her research centers on advanced electrochemical processes for treating pharmaceutical wastewater. Her doctoral work reflects a deep commitment to environmental protection and technological innovation, with a focus on optimizing electrochemical and membrane-based systems for effective pollutant removal.As part of her ongoing research, Ms. Gouider is conducting a research internship at the CNRS / Institut Européen des Membranes in Montpellier, France. Her current project explores the integration of electrochemical and membrane technologies for the depollution of complex industrial effluents, bridging the gap between laboratory research and real-world environmental applications. Her scientific curiosity and methodological precision allow her to design, test, and model innovative approaches that contribute to the global effort toward sustainable water management.Ms. Gouider holds a Master’s degree in Materials and Environmental Chemistry and a National License in Chemistry from the Faculty of Sciences of Gabès, following a solid foundation in experimental sciences acquired during her early studies. Her academic path has equipped her with strong analytical, experimental, and statistical skills, including expertise in advanced experimental design, response surface methodology, multivariate optimization, and analysis of variance (ANOVA). She is proficient in using specialized software such as Nemrod and Microsoft Office tools for data analysis, scientific reporting, and presentation.Her publication titled “Treatment of pharmaceutical industry effluent using conventional and pulsed electrocoagulation on iron electrodes: Optimization using response surface methodology” published in Total Environment Engineering (Elsevier) highlights her innovative approach in applying electrochemical methods to optimize effluent treatment processes. This work demonstrates her ability to combine theoretical modeling with experimental validation to enhance the performance and sustainability of industrial water treatment systems.Ms. Gouider’s research has been presented at several national and international scientific events, including Euro-Africa Congresses and water-related scientific forums, where she actively contributes to discussions on environmental protection and technological advancement. Known for her organizational skills, teamwork, and dedication, she continues to pursue excellence in scientific communication, applied research, and interdisciplinary collaboration, driven by her vision of creating cleaner technologies for a sustainable future.

Profile: Orcid

Featured Publications

Gouider, A., Zaabtia, A., Khalifa, M., Ba, M., & Ammar, S. (2025). Treatment of pharmaceutical industry effluent using conventional and pulsed electrocoagulation on iron electrodes: Optimization using response surface methodology. Total Environment Engineering, 100048.

Ruby Anto | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Ruby Anto | Drug Discovery and Development | Best Researcher Award

Centre of Excellence in Nutraceuticals | India

Dr. Ruby Anto is a distinguished biochemist and cancer researcher with an extensive career dedicated to advancing the fields of molecular oncology, bioimmunotherapy, and nutraceutical science. She currently serves as Chief Scientist at the Centre of Excellence in Nutraceuticals, KSCSTE, Government of Kerala, Thiruvananthapuram, and Honorary Scientist at the Institute of Advanced Virology, Thiruvananthapuram. Over her accomplished career, she has held numerous scientific positions at the Rajiv Gandhi Centre for Biotechnology, progressing from Research Associate to Scientist G, reflecting her consistent contributions and leadership in biomedical research.Dr. Anto earned her PhD in Biochemistry from Amala Cancer Research Centre, Thrissur, following her postgraduate studies in Chemistry and Education. Her multidisciplinary academic background—combining chemistry, biochemistry, and pedagogy—has been central to her innovative approach to cancer biology and molecular medicine. Her early academic achievements and later professional experiences at prestigious institutions such as the M.D. Anderson Cancer Center, Houston, provided a strong foundation for her research on targeted cancer therapies, chemopreventive agents, and the role of natural products in disease modulation.Recognized nationally and internationally for her scientific excellence, Dr. Anto has received several prestigious honors, including the Young National Women Bio-Scientist Award from the Department of Biotechnology, Government of India, and fellowships from the National Academy of Sciences, India, and the Academy of Sciences, Thiruvananthapuram. Her professional journey also includes global training experiences, such as her participation in the Clinical Trials Traineeship Program at INSERM, Paris, which broadened her expertise in translational research and clinical validation of nutraceutical interventions.As a mentor, Dr. Anto has nurtured a generation of young scientists, with her students and postdoctoral fellows earning numerous national and international awards for their work in cancer biology and nutraceutical research. Her leadership has fostered a thriving academic environment focused on the discovery and characterization of bioactive compounds from natural sources with therapeutic potential.Dr. Anto’s scientific publications have advanced understanding in areas such as natural compound-mediated cancer prevention, signaling pathway modulation, and anti-inflammatory mechanisms of nutraceuticals. Through her research, she continues to bridge the gap between basic biochemistry and applied health sciences, promoting nutraceutical innovation as a cornerstone of preventive and personalized medicine. Her lifelong dedication to scientific inquiry and mentorship underscores her status as one of India’s leading voices in biochemistry and nutraceutical research.

Profile: Google Scholar

Featured Publications

Ruby, A. J., Kuttan, G., Babu, K. D., Rajasekharan, K. N., & Kuttan, R. (1995). Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Letters, 94(1), 79–83.

Anto, R. J., Mukhopadhyay, A., Denning, K., & Aggarwal, B. B. (2002). Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: Its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis, 23(1), 143–150.

Anto, R. J., Sukumaran, K., Kuttan, G., Rao, M. N. A., Subbaraju, V., & Kuttan, R. (1995). Anticancer and antioxidant activity of synthetic chalcones and related compounds. Cancer Letters, 97(1), 33–37.

Oommen, S., Anto, R. J., Srinivas, G., & Karunagaran, D. (2004). Allicin (from garlic) induces caspase-mediated apoptosis in cancer cells. European Journal of Pharmacology, 485(1–3), 97–103.*

Anto, R. J., Mukhopadhyay, A., Shishodia, S., Gairola, C. G., & Aggarwal, B. B. (2002). Cigarette smoke condensate activates nuclear transcription factor-κB through phosphorylation and degradation of IκBα: Correlation with induction of cyclooxygenase-2. Carcinogenesis, 23(9), 1511–1518.*

Bava, S. V., Puliappadamba, V. T., Deepti, A., Nair, A., Karunagaran, D., & Anto, R. J. (2005). Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-κB and the serine/threonine kinase Akt and is independent of tubulin polymerization. Journal of Biological Chemistry, 280(8), 6301–6308.*

Srinivas, G., Anto, R. J., Srinivas, P., Vidhyalakshmi, S., Senan, V. P., & Karunagaran, D. (2003). Emodin induces apoptosis of human cervical cancer cells through poly (ADP-ribose) polymerase cleavage and activation of caspase-9. European Journal of Pharmacology, 473(2–3), 117–125.*

Jiaojiao Liang | Herbal Medicine and Nutraceuticals | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Jiaojiao Liang | Herbal Medicine and Nutraceuticals | Best Researcher Award

Weihai Agricultural and Rural Affairs Service Center | China

Dr. Jiaojiao Liang is an accomplished agronomist with a profound research focus on fruit nutrition and consumption guidance. She earned her doctoral degree from Zhejiang University, where she was directly admitted to the Ph.D. program through postgraduate recommendation, a recognition of her outstanding academic performance and research potential. Her academic journey has been deeply rooted in the field of Pomology, where she has dedicated herself to exploring the nutritional value and functional benefits of fruits, with a particular emphasis on the extraction and utilization of natural bioactive compounds.Dr. Liang’s scientific endeavors primarily revolve around the identification and functional evaluation of natural products derived from fruits, such as flavonoids in citrus peels and anthocyanins in specialty berries. Her research integrates modern analytical techniques with biological evaluation models to uncover the therapeutic potential of these compounds in combating oxidative stress, inflammation, and cellular damage. Through her studies, she has provided new insights into the use of fruit-derived bioactives as potential dietary interventions for health promotion and disease prevention.As an emerging scholar in her field, Dr. Liang ohas co-authored several impactful publications in highly regarded scientific journals, including Food Chemistry, Critical Reviews in Food Science and Nutrition, Food Frontiers, and Food Science & Nutrition. Her works have explored diverse topics such as the protective effects of anthocyanin extracts from superfruits against cadmium-induced oxidative stress, the apoptotic mechanisms of limonin in cancer cells, and the hepatoprotective potential of flavonoid-rich fruit extracts. Her review on nobiletin as a chemopreventive natural product has been particularly noted for its comprehensive synthesis of current advancements in phytochemical research.Dr. Liang has also contributed significantly to collaborative research initiatives, particularly with the Hainan Institute of Zhejiang University, where she has participated in both completed and ongoing projects examining the bioactivity of flavonoids under environmental stress conditions. Her work in establishing cellular models to evaluate antioxidant enzyme activities, inflammatory biomarkers, and gene expression has strengthened the understanding of how fruit-based compounds interact with human biological systems.

Profile: Orcid

Featured Publications

Chen, Y.-Y., Liang, J.-J., Wang, D.-L., Chen, J.-B., Cao, J.-P., Wang, Y., & Sun, C.-D. (2023). Nobiletin as a chemopreventive natural product against cancer: A comprehensive review. Critical Reviews in Food Science and Nutrition.